Search

everythinglearnresearchcommunity

for

Search:↓

Thorough patient interviews are crucial to identify self-inflicted hair loss.

Narrowband Ultraviolet B treatment can significantly reduce anxiety in psoriasis patients, but it doesn't significantly affect depression.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.

The interdisciplinary approach improved the quality of life for a Parkinson's patient and eased staff workload.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Post-finasteride syndrome may be linked to pre-existing psychological issues, not just the drug.

Higher CSF 5-HIAA levels may predict better response to serotonin re-uptake inhibitors in trichotillomania.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Hair loss significantly affects quality of life and mental health, causing anxiety and depression.

Improving symptoms of male urinary problems may lower the risk of death.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Alopecia areata greatly affects the quality of life for children and their families.

Early detection of apolipoprotein levels helps reduce depression risk in the elderly.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

Finasteride and dutasteride increase sexual dysfunction reports.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

The HSVS-A is an effective tool for quickly screening hair shedding in Asian women.

Men with better urinary symptoms have a lower risk of death.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Patients with Alopecia Areata often have higher anxiety and depression.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Semaglutide may worsen eating disorders in vulnerable individuals.

Alopecia areata in children often leads to anxiety, depression, and other mental health issues, affecting their quality of life.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.